Royalty Pharma plc
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $812.0M | $586.4M | $618.7M | $938.9M | $631.9M | $1.09B | $929.0M | $950.1M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $1.76B | $1.43B | $1.53B | $1.85B | $1.52B | $1.84B | $1.80B | $1.79B |
| Property, Plant & Equipment | — | — | — | — | — | — | — | — |
| Goodwill | $923.5M | $924.6M | $924.6M | $924.6M | $924.6M | — | $0 | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $19.82B | $19.82B | $19.62B | $19.35B | $18.32B | $17.61B | $18.22B | $18.04B |
| Liabilities | ||||||||
| Accounts Payable | — | — | — | — | — | — | — | — |
| Total Current Liabilities | $630.9M | $535.7M | $636.2M | $530.8M | $1.21B | $1.18B | $1.25B | $1.17B |
| Long-Term Debt | $8.58B | $8.58B | $8.57B | $8.57B | $7.00B | $6.62B | $6.61B | $6.61B |
| Total Liabilities | $10.03B | $9.88B | $9.91B | $9.73B | $8.82B | $7.82B | $7.88B | $7.78B |
| Stockholders' Equity | ||||||||
| Retained Earnings | $2.46B | $2.51B | $2.36B | $2.30B | $2.22B | $2.48B | $2.85B | $2.76B |
| Total Stockholders' Equity | $9.79B | $9.94B | $9.71B | $9.62B | $9.49B | $9.78B | $10.34B | $10.26B |